Rankings
▼
Calendar
TMDX Q4 2025 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena
TMDX
TransMedics Group, Inc.
$5B
Q4 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$161M
+32.2% YoY
Gross Profit
$93M
58.1% margin
Operating Income
$21M
13.2% margin
Net Income
$105M
65.6% margin
EPS (Diluted)
$2.59
QoQ Revenue Growth
+11.8%
Cash Flow
Operating Cash Flow
$35M
Free Cash Flow
$19M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$1.1B
Total Liabilities
$595M
Stockholders' Equity
$473M
Cash & Equivalents
$488M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$161M
$122M
+32.2%
Gross Profit
$93M
$72M
+29.7%
Operating Income
$21M
$9M
+146.1%
Net Income
$105M
$7M
+1436.9%
Revenue Segments
Product
$100M
100%
← FY 2025
All Quarters